撤回：基于肿瘤免疫评分分类的肝细胞癌新型线粒体自噬相关基因预后特征的开发与验证。
Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
作者信息
Oncology Journal Of
出版信息
J Oncol. 2023 Oct 11;2023:9803262. doi: 10.1155/2023/9803262. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2021/5070099.].
摘要
[本文撤回文章DOI: 10.1155/2021/5070099。]
相似文献
1
Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.撤回：基于肿瘤免疫评分分类的肝细胞癌新型线粒体自噬相关基因预后特征的开发与验证。
J Oncol. 2023 Oct 11;2023:9803262. doi: 10.1155/2023/9803262. eCollection 2023.
2
Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.基于肿瘤免疫评分分类的肝细胞癌新型线粒体自噬相关基因预后标志物的开发与验证
J Oncol. 2021 Oct 25;2021:5070099. doi: 10.1155/2021/5070099. eCollection 2021.
3
A novel immune-related genes prognosis biomarker for hepatocellular carcinoma.一种新型的肝癌免疫相关基因预后生物标志物。
Aging (Albany NY). 2020 Nov 26;13(1):675-693. doi: 10.18632/aging.202173.
4
Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.撤回：用于预测肝细胞癌患者总生存期的mTORC1信号相关基因特征的建立与验证。
Biomed Res Int. 2024 Mar 20;2024:9851737. doi: 10.1155/2024/9851737. eCollection 2024.
5
Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.肿瘤浸润免疫细胞对乙型肝炎病毒相关性肝细胞癌预后预测的意义。
World J Gastroenterol. 2019 Sep 21;25(35):5266-5282. doi: 10.3748/wjg.v25.i35.5266.
6
Retracted: Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.撤回：用于预测肝细胞癌患者生存的胆汁酸相关基因特征的开发。
Comput Math Methods Med. 2023 Dec 6;2023:9865740. doi: 10.1155/2023/9865740. eCollection 2023.
7
Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.撤回：鉴定和验证一种炎症反应相关多基因风险评分作为肝细胞癌的预后标志物
Dis Markers. 2023 Jul 26;2023:9809678. doi: 10.1155/2023/9809678. eCollection 2023.
8
A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma.一种与线粒体自噬相关的基因特征，用于鉴定肝细胞癌的亚型并预测其预后。
Int J Mol Sci. 2022 Oct 12;23(20):12123. doi: 10.3390/ijms232012123.
9
A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.基于癌症基因组图谱的新型预后免疫评分，用于预测结直肠癌患者的总生存期。
Biosci Rep. 2021 Oct 29;41(10). doi: 10.1042/BSR20210039.
10
Retracted: New Pyroptosis-Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma.撤回：用于预测肝细胞癌患者总生存期的新的焦亡相关基因特征。
J Healthc Eng. 2023 Aug 16;2023:9809725. doi: 10.1155/2023/9809725. eCollection 2023.
本文引用的文献
1
Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.基于肿瘤免疫评分分类的肝细胞癌新型线粒体自噬相关基因预后标志物的开发与验证
J Oncol. 2021 Oct 25;2021:5070099. doi: 10.1155/2021/5070099. eCollection 2021.
Zotero 插件